CompletedNCT02544074eSAGEUpdated Mar 25, 2025Results posted

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

An observational study in Mild Cognitive Impairment and Dementia, sponsored by Ohio State University. Completed at 1 site in United States. Open to participants aged 50 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-25.

Sponsored by Ohio State University · Observational

Study type: Observational
Model: Other
Time perspective: Prospective
Enrollment: 69
Ages: 50 Years and older
Sex: All

Study summary

The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia. SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable forms allows it to be given in almost any setting, does not require any staff time to administer and makes it practical to rapidly screen large numbers of individuals in the community or in their home.This trial is being conducted to study the validity of SAGE in a digital format (eSAGE) for cognitive screening.

The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.

Addendum:

The eSAGE was previously validated in an earlier stage of this trial. It was initially designed for tablet use and the exact same test has recently been formatted for smartphone use.

This addendum is being conducted to study the validity of the smartphone eSAGE compared to the tablet eSAGE for cognitive screening.

Read the detailed description

Participants will be recruited based on their eSAGE scores and evaluated with neuropsychological testing and medical history to determine their status as normal, mild cognitive impairment, or dementia.

Addendum:

Subjects will be scheduled for a one time visit where they will be administered both the tablet eSAGE and the smartphone eSAGE. eSAGE tablet scores will be compared to eSAGE smartphone scores to determine if the two formats are equivalent to each other.

Conditions studied

Mild Cognitive Impairment
Dementia

Browse trials for

Cognitive Dysfunction 3,843

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's enrollment of 69 is below the median of 150 across 950 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

Who can participate

Ages eligible: 50 Years and older
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Probability sample

Study population

Subjects will be recruited from a wide variety of community events including senior centers, health fairs, educational talks to lay public, independent and assisted living facilities, and free memory screens as well as from ambulatory Geriatric or Memory Disorders Clinics. The SAGE cognitive screening tool will be given to all subjects willing to take the test.Participants who complete the SAGE test and meet inclusion and exclusion criteria will be divided into groups based on their initial SAGE scores. Each group will be composed of subjects with the same score. Individuals will be randomly selected from each group and asked to further participate in a one-time clinical evaluation.

Addendum:

Subjects will be recruited from community events and our clinic and research center.

Inclusion criteria

Adults over 49 years old of either gender
Vision and hearing sufficient for compliance with tests

Exclusion criteria

Exclusion Criteria:

Diagnosis by a physician of moderate or severe dementia
Intellectual disability

Study design

Observational model: Other
Time perspective: Prospective
Enrollment: 69 participants (actual)
Patient registry: No

Groups and cohorts

eSAGE score of 10
Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 11
Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 12
Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 13
Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 14
Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 15
Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 16
Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 17
Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 18
Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 19
Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 20
Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 21
Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 22
Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 9
Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 8
Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 6
Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 7
Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 5
Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 4
Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 3
Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
eSAGE score of 2
Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing.
Behavioral: neuropsychological testing
Smartphone eSAGE score of 13
Participants who score a 13 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 14
Participants who score a 14 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 15
Participants who score a 15 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 16
Participants who score a 16 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 17
Participants who score a 17 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 18
Participants who score a 18 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 19
Participants who score a 19 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 20
Participants who score a 20 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 21
Participants who score a 21 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing
Smartphone eSAGE score of 22
Participants who score a 22 on the smartphone eSAGE. Interventions include neuropsychological testing.
Behavioral: eSAGE testing

Interventions

Behavioralneuropsychological testing
standard neuropsychological testing including brief standardized assessments
BehavioraleSAGE testing
Neuropsychological testing including the eSAGE tablet and eSAGE smartphone

What researchers measure

Primary outcomes

eSAGE Score Compared to the Sum of the Neuropsychological Measures.
Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include: * Boston Naming Test * Wisconsin Card Sort Task (WCST) * Hopkins Verbal Learning Test (HVLT) * FAS verbal fluency task * Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests Associations will be investigated using Spearman correlations.
Time frame: 3 Hours

Secondary outcomes

eSAGE Score Compared to the Paper SAGE Score
The investigators will compare the subject's scores on the SAGE in digital format to their paper SAGE scores to determine if these two formats are equivalent to each other. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score
The investigators will compare the eSAGE scores with the Mini-Mental State Examination (MMSE) scores. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score
The investigators will compare the eSAGE scores with the Montreal Cognitive Assessment (MoCA) scores. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Boston Naming Test Score
The investigators will compare the eSAGE scores to the Boston Naming Test score. The Boston Naming Test consists of 60 pictures of nouns that subjects must try to name. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score
The investigators will compare the eSAGE scores to the Wisconsin Card Sort Task (WCST) perseverative errors scores. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score
The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) total learning scores. Associations will be investigated using Spearman correlations. The investigators will also compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) delayed recall scores. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compare to the FAS Verbal Fluency Task Score
The investigators will compare the eSAGE scores to the FAS Verbal Fluency Task scores. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score
The investigators will compare the eSAGE scores to the WAIS III Letter-number scores. The WAIS III Letter-number test asks subjects to recall a series of numbers in increasing order and letters in alphabetical order. Associations will be investigated using Spearman correlations.
Time frame: 3 hours
eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score
The investigators will compare the eSAGE scores to the WAIS III Block Design scores. The WAIS III Block Design requires the replication of red and white designs using three-dimensional colored blocks. Associations will be investigated using Spearman correlations.
Time frame: 3 hours

Results

Posted Nov 6, 2017

Limitations and caveats

The majority of the subjects were Caucasian and highly educated. Results may be limited based on where the patients were recruited and their range of cognitive abilities. The ADCS-ADL scale was used as self-report in subjects without a study partner.

Participant flow

Participant flow — Overall Study
Milestone	eSAGE Score of 2	eSAGE Score of 3	eSAGE Score of 4	eSAGE Score of 5	eSAGE Score of 6	eSAGE Score of 7	eSAGE Score of 8	eSAGE Score of 9	eSAGE Score of 10	eSAGE Score of 11	eSAGE Score of 12	eSAGE Score of 13	eSAGE Score of 14	eSAGE Score of 15	eSAGE Score of 16	eSAGE Score of 17	eSAGE Score of 18	eSAGE Score of 19	eSAGE Score of 20	eSAGE Score of 21	eSAGE Score of 22
Started	1	1	1	1	4	1	2	4	6	2	2	3	4	5	5	8	6	3	4	3	3
Completed	1	0	1	1	4	0	2	4	6	1	2	3	4	5	5	8	6	3	4	3	3
Not completed	0	1	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0
Withdrew: Withdrawal by subject	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Withdrew: Tablet error	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0

Outcome measures

PrimaryeSAGE Score Compared to the Sum of the Neuropsychological Measures.

Analysis will consist of comparing the subject's scores on the SAGE in digital format to their neuropsychological test scores. This will be a composite score of the neuropsychological testing scores. The neuropsychological measures include: * Boston Naming Test * Wisconsin Card Sort Task (WCST) * Hopkins Verbal Learning Test (HVLT) * FAS verbal fluency task * Wechsler Adult Intelligence Scale III (WAIS III) Letter-number and block design subtests Associations will be investigated using Spearman correlations.

Time frame:: 3 Hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Sum of the Neuropsychological Measures.
spearman rank correlation	eSAGE Score Compared to the Sum of Neuropsychological Measures
eSAGE Score Compared to the Sum of the Neuropsychological Measures.	0.7292

SecondaryeSAGE Score Compared to the Paper SAGE Score

The investigators will compare the subject's scores on the SAGE in digital format to their paper SAGE scores to determine if these two formats are equivalent to each other. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Paper SAGE Score
spearman rank correlation	eSAGE Score Compared to the Paper SAGE Score
eSAGE Score Compared to the Paper SAGE Score	0.8824

SecondaryeSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score

The investigators will compare the eSAGE scores with the Mini-Mental State Examination (MMSE) scores. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score
spearman rank correlation	eSAGE Score Compared to the Mini-Mental State Exam Score
eSAGE Score Compared to the Mini-Mental State Examination (MMSE) Score	0.6711

SecondaryeSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score

The investigators will compare the eSAGE scores with the Montreal Cognitive Assessment (MoCA) scores. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score
spearman rank correlation	eSAGE Score Compared to the MoCA Score
eSAGE Score Compared to the Montreal Cognitive Assessment (MoCA) Score	0.7577

SecondaryeSAGE Score Compared to the Boston Naming Test Score

The investigators will compare the eSAGE scores to the Boston Naming Test score. The Boston Naming Test consists of 60 pictures of nouns that subjects must try to name. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Boston Naming Test Score
spearman rank correlation	eSAGE Score Compared to the Boston Naming Test Score
eSAGE Score Compared to the Boston Naming Test Score	0.3487

SecondaryeSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score

The investigators will compare the eSAGE scores to the Wisconsin Card Sort Task (WCST) perseverative errors scores. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score
spearman rank correlation	eSAGE Score Compared to the WCST Score
eSAGE Score Compared to the Wisconsin Card Sort Task (WCST) Score	0.4596

SecondaryeSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score

The investigators will compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) total learning scores. Associations will be investigated using Spearman correlations. The investigators will also compare the eSAGE scores to the Hopkins Verbal Learning Test (HVLT) delayed recall scores. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score
spearman rank correlation	eSAGE Score Compared to the HVLT Total Learning Score	eSAGE Score Compared to the HVLT Delayed Recall Score
eSAGE Score Compared to the Hopkins Verbal Learning Test (HVLT) Score	0.6045	0.4866

SecondaryeSAGE Score Compare to the FAS Verbal Fluency Task Score

The investigators will compare the eSAGE scores to the FAS Verbal Fluency Task scores. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compare to the FAS Verbal Fluency Task Score
spearman rank correlation	eSAGE Score Compared to the FAS Verbal Fluency Task Score
eSAGE Score Compare to the FAS Verbal Fluency Task Score	0.3210

SecondaryeSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score

The investigators will compare the eSAGE scores to the WAIS III Letter-number scores. The WAIS III Letter-number test asks subjects to recall a series of numbers in increasing order and letters in alphabetical order. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score
spearman rank correlation	eSAGE Score Compared to the WAIS III Letter-number Score
eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Letter-number Score	0.5349

SecondaryeSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score

The investigators will compare the eSAGE scores to the WAIS III Block Design scores. The WAIS III Block Design requires the replication of red and white designs using three-dimensional colored blocks. Associations will be investigated using Spearman correlations.

Time frame:: 3 hours
Reported as:: Number · spearman rank correlation

eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score
spearman rank correlation	eSAGE Score Compared to the WAIS III Block Design Score
eSAGE Score Compared to the Wechsler Adult Intelligence Scale III (WAIS III) Block Design Score	0.5774

Adverse events

Collected over Adverse event data was collected for 1 day, the day of the study visit.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
Group	Deaths	Serious	Other
eSAGE Score of 2	0/1 (0%)	0/1 (0%)	0/1 (0%)
eSAGE Score of 3	0/1 (0%)	0/1 (0%)	0/1 (0%)
eSAGE Score of 4	0/1 (0%)	0/1 (0%)	0/1 (0%)
eSAGE Score of 5	0/1 (0%)	0/1 (0%)	0/1 (0%)
eSAGE Score of 6	0/4 (0%)	0/4 (0%)	0/4 (0%)
eSAGE Score of 7	0/1 (0%)	0/1 (0%)	0/1 (0%)
eSAGE Score of 8	0/2 (0%)	0/2 (0%)	0/2 (0%)
eSAGE Score of 9	0/4 (0%)	0/4 (0%)	0/4 (0%)
eSAGE Score of 10	0/6 (0%)	0/6 (0%)	0/6 (0%)
eSAGE Score of 11	0/2 (0%)	0/2 (0%)	0/2 (0%)
eSAGE Score of 12	0/2 (0%)	0/2 (0%)	0/2 (0%)
eSAGE Score of 13	0/3 (0%)	0/3 (0%)	0/3 (0%)
eSAGE Score of 14	0/4 (0%)	0/4 (0%)	0/4 (0%)
eSAGE Score of 15	0/5 (0%)	0/5 (0%)	0/5 (0%)
eSAGE Score of 16	0/5 (0%)	0/5 (0%)	0/5 (0%)
eSAGE Score of 17	0/8 (0%)	0/8 (0%)	0/8 (0%)
eSAGE Score of 18	0/6 (0%)	0/6 (0%)	0/6 (0%)
eSAGE Score of 19	0/3 (0%)	0/3 (0%)	0/3 (0%)
eSAGE Score of 20	0/4 (0%)	0/4 (0%)	0/4 (0%)
eSAGE Score of 21	0/3 (0%)	0/3 (0%)	0/3 (0%)
eSAGE Score of 22	0/3 (0%)	0/3 (0%)	0/3 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)	eSAGE Score of 2	eSAGE Score of 3	eSAGE Score of 4	eSAGE Score of 5	eSAGE Score of 6	eSAGE Score of 7	eSAGE Score of 8	eSAGE Score of 9	eSAGE Score of 10	eSAGE Score of 11	eSAGE Score of 12	eSAGE Score of 13	eSAGE Score of 14	eSAGE Score of 15	eSAGE Score of 16	eSAGE Score of 17	eSAGE Score of 18	eSAGE Score of 19	eSAGE Score of 20	eSAGE Score of 21	eSAGE Score of 22	Total
<=18 years	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Between 18 and 65 years	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	3	0	0	0	0	1	6
>=65 years	1	1	1	1	4	1	2	4	6	2	2	3	4	4	4	5	6	3	4	3	2	63

Sex: Female, Male
Sex: Female, Male(Participants)	eSAGE Score of 2	eSAGE Score of 3	eSAGE Score of 4	eSAGE Score of 5	eSAGE Score of 6	eSAGE Score of 7	eSAGE Score of 8	eSAGE Score of 9	eSAGE Score of 10	eSAGE Score of 11	eSAGE Score of 12	eSAGE Score of 13	eSAGE Score of 14	eSAGE Score of 15	eSAGE Score of 16	eSAGE Score of 17	eSAGE Score of 18	eSAGE Score of 19	eSAGE Score of 20	eSAGE Score of 21	eSAGE Score of 22	Total
Female	0	0	0	1	3	0	0	3	4	1	2	2	2	4	2	7	3	2	3	2	3	44
Male	1	1	1	0	1	1	2	1	2	1	0	1	2	1	3	1	3	1	1	1	0	25

Race (NIH/OMB)
Race (NIH/OMB)(Participants)	eSAGE Score of 2	eSAGE Score of 3	eSAGE Score of 4	eSAGE Score of 5	eSAGE Score of 6	eSAGE Score of 7	eSAGE Score of 8	eSAGE Score of 9	eSAGE Score of 10	eSAGE Score of 11	eSAGE Score of 12	eSAGE Score of 13	eSAGE Score of 14	eSAGE Score of 15	eSAGE Score of 16	eSAGE Score of 17	eSAGE Score of 18	eSAGE Score of 19	eSAGE Score of 20	eSAGE Score of 21	eSAGE Score of 22	Total
American Indian or Alaska Native	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Asian	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	2
Native Hawaiian or Other Pacific Islander	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Black or African American	0	0	0	0	1	0	0	0	0	0	0	0	0	2	1	1	0	0	0	0	0	5
White	1	1	1	1	3	1	2	3	6	2	2	3	4	2	4	7	6	2	3	3	3	60
More than one race	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Unknown or Not Reported	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	2

Study locations

1 site

The Ohio State University
Columbus, Ohio 43221, United States

References and documents

Publications

Scharre DW, Chang SI, Nagaraja HN, Vrettos NE, Bornstein RA. Digitally translated Self-Administered Gerocognitive Examination (eSAGE): relationship with its validated paper version, neuropsychological evaluations, and clinical assessments. Alzheimers Res Ther. 2017 Jun 27;9(1):44. doi: 10.1186/s13195-017-0269-3. PubMed 28655351 ↗

Study documents

Protocol and statistical analysis plan · Jan 10, 2017

Documents are hosted by the registry — open the source record to download them.

Updates

Tracking since Sep 25, 2026

No changes since tracking began. The registry record was last updated on Mar 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT02544074
Lead sponsor: Ohio State University
Collaborators: Brain Test, Inc.
Responsible party: Douglas Scharre (Professor, Ohio State University) — Principal investigator
First posted: Sep 9, 2015
Start date: Jan 2015
Primary completion: Nov 13, 2024
Completion: Nov 13, 2024
Results posted: Nov 6, 2017
Last update: Mar 25, 2025

Study contacts

Douglas Scharre, M.D.

principal investigator · Ohio State University

Oversight

Data monitoring committee: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Cognitive Dysfunction→

Other studies from this sponsor

Ohio State University

Start the discussion

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

Study summary

Conditions studied

Browse trials for

In context

Cognitive Dysfunction

Lead sponsor

Who can participate

Study population

✓Inclusion criteria

✕Exclusion criteria

Study design

Groups and cohorts

Interventions

What researchers measure

Primary outcomes

Secondary outcomes

Results

Participant flow

Outcome measures

Adverse events

Baseline characteristics

Study locations

References and documents

Publications

Study documents

Updates

Registry details

Key details

Study contacts

Oversight

Not currently enrolling

Follow this study

Discussion

Other studies in this condition

Other studies from this sponsor

Inclusion criteria

Exclusion criteria